Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Cancer Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT03552796
What this trial is testing

SEphB4-HSA in Treating Participants With BCG-Unresponsive or Refractory Bladder Cancer

Who this might be right for
Recurrent Bladder CarcinomaBladder Cancer Stage 0Bladder Cancer Stage I
University of Southern California
Testing effectiveness (Phase 2)Study completedNCT00003759
What this trial is testing

AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer

Who this might be right for
Bladder Cancer
Anthra Pharmaceuticals
Very early researchStudy completedNCT01240824
What this trial is testing

Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer

Who this might be right for
Bladder Cancer
University of Virginia 3
Not applicableEnded earlyNCT01495676
What this trial is testing

A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer

Who this might be right for
Infiltrating Bladder Urothelial Carcinoma
Institut du Cancer de Montpellier - Val d'Aurelle 69
Large-scale testing (Phase 3)Study completedNCT00002990
What this trial is testing

Surgery and BCG in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
European Organisation for Research and Treatment of Cancer - EORTC 1,288
Early research (Phase 1)UnknownNCT03934827
What this trial is testing

MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour

Who this might be right for
MelanomaBreast CancerUterine Cancer+7 more
Imperial College London 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06829823
What this trial is testing

Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
ImmunityBio, Inc. 20
Early research (Phase 1)Looking for participantsNCT07483970
What this trial is testing

A Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With High Risk Non-Muscle Invasive Bladder Cancer.

Who this might be right for
High Risk Non-muscle Invasive Bladder Cancer
Jecho Biopharmaceuticals Co., Ltd. 18
Testing effectiveness (Phase 2)Study completedNCT05253053
What this trial is testing

To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorCholangiocarcinomaBiliary Tract Cancer+8 more
TransThera Sciences (Nanjing), Inc. 84
Large-scale testing (Phase 3)Looking for participantsNCT07804056
What this trial is testing

Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants With Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder Cancer

Who this might be right for
Urinary Bladder NeoplasmsNon-muscle Invasive Bladder Cancer (NMIBC)
Hamlet Pharma AB 194
Early research (Phase 1)Study completedNCT00413322
What this trial is testing

Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors

Who this might be right for
Tumor
Valerio Therapeutics 35
Testing effectiveness (Phase 2)Study completedNCT00526656
What this trial is testing

Sunitinib in Treating Patients With Locally Advanced Bladder Cancer

Who this might be right for
Bladder Cancer
Case Comprehensive Cancer Center 9
Testing effectiveness (Phase 2)Looking for participantsNCT03945162
What this trial is testing

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Who this might be right for
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
Theralase® Technologies Inc. 90
Testing effectiveness (Phase 2)Looking for participantsNCT06732531
What this trial is testing

Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerNon Muscle Invasive
Zhuhai Beihai Biotech Co., Ltd 48
Early research (Phase 1)Study completedNCT00635336
What this trial is testing

Novel Peptide Vaccination for Patients With Advanced Bladder Cancer

Who this might be right for
Bladder Cancer
Iwate Medical University 20
Early research (Phase 1)Looking for participantsNCT06778863
What this trial is testing

CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorMetastatic Solid Tumor+8 more
Clasp Therapeutics, Inc. 90
Early research (Phase 1)Ended earlyNCT02925533
What this trial is testing

Ph 1B B-701 in Combination With Pembrolizumab in Metastatic Transitional Cell Carcinoma of the Urothelial Tract

Who this might be right for
Bladder Cancer
Mark Pomerantz, MD 1
Early research (Phase 1)Study completedNCT01517464
What this trial is testing

A Phase I Study of Systemic Gene Therapy With SGT-94 in Patients With Solid Tumors

Who this might be right for
Neoplasm
SynerGene Therapeutics, Inc. 13
Testing effectiveness (Phase 2)UnknownNCT06009848
What this trial is testing

Cadonilimab Plus Nab-Paclitaxel for Recurrent or Metastatic Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Tianjin Medical University Second Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT00363883
What this trial is testing

Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium

Who this might be right for
Localized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter+2 more
National Cancer Institute (NCI) 14
Next Page